Centralized Reminder Recall - Flu RCT2
NCT03294473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70190
Last updated 2019-06-05
Summary
This study is related to a previous study, Clinicaltrials.gov ID: NCT02924467. There are some modifications in relation to the intervention arms as well as the use of a different cohort, thereby justifying the second submission to Clinicaltrials.gov. This trial is taking place in New York State, through partnership with the New York State Health Department (excluding New York City), and Colorado. Each state will have it's own Clinicaltrial.gov submission -- this was decided as some of the intervention components are different enough that separate registrations were warranted.
Despite U.S. guidelines for influenza vaccination of all children starting at 6 months, only about half of children are vaccinated annually leading to substantial influenza disease in children and spread of disease to adults. A major barrier is that families are not reminded about the need for their children to receive influenza vaccination. The investigators will evaluate the impact of patient reminder/recall (R/R) performed by state immunization information systems to improve influenza vaccination rates by using 4 clinical trials (2 per state) in two different states. The investigators will assess effectiveness and cost-effectiveness of 1) autodialer R/R 2) text messages R/R 3) mailed postcard R/R as compared to 4) standard of care control (no R/R).
Conditions
- Influenza, Human
- Orthomyxoviridae Infections
- RNA Virus Infections
- Virus Disease
- Respiratory Tract Infections
- Respiratory Tract Disease
- Vaccines
- Physiological Effects of Drugs
Interventions
- BEHAVIORAL
-
R/R - Autodialers
Investigators will send out flu vaccine reminder recall notices via autodialer message to the parents of children 6 months - 17 years of age who are due for the flu vaccine, per the records in the New York State Immunization Information System (NYSIIS).
- BEHAVIORAL
-
R/R - Texting
Investigators will send out flu vaccine reminder recall notices via text message to the parents of children 6 months - 17 years of age who are due for the flu vaccine, per the records in the New York State Immunization Information System (NYSIIS).
- BEHAVIORAL
-
R/R - mailed postcard
Investigators will send out flu vaccine reminder recall notices via mailed postcards to the parents of children 6 months - 17 years of age who are due for the flu vaccine, per the records in the New York State Immunization Information System (NYSIIS).
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
New York State Department of Health
collaborator OTHER_GOV -
University of Colorado, Denver
collaborator OTHER -
University of California, Los Angeles
lead OTHER
Principal Investigators
-
Peter Szilagyi, MD, MPH · University of California, Los Angeles
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-18
- Primary Completion
- 2018-04-19
- Completion
- 2018-05-04
Countries
- United States
Study Locations
More Related Trials
-
Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- RCT 2
NCT04110314 ·Status: COMPLETED ·Phase: NA
-
Patient Portal Flu Vaccine Reminders (5)
NCT05525494 ·Status: COMPLETED ·Phase: NA
-
Pediatric Second Influenza Dose Portal Reminder Recall
NCT04668417 ·Status: COMPLETED ·Phase: NA
-
Impact on Influenza Vaccination Rates of a Telephone Text Message Recall From the Attending Physician
NCT06123936 ·Status: RECRUITING ·Phase: NA
-
Patient Portal Flu Vaccine Reminders_RCT 4
NCT05052190 ·Status: TERMINATED ·Phase: NA
-
Adult Influenza Vaccination Text Message Reminders With Electronic Health Record Alerts
NCT02284594 ·Status: COMPLETED ·Phase: NA
-
Patient Portal Flu Vaccine Reminders (RCT 6)
NCT06062264 ·Status: COMPLETED ·Phase: NA
-
Patient Portal Flu Vaccine Reminders_RCT 5 (LADHS)
NCT05535777 ·Status: COMPLETED ·Phase: NA
-
Influenza Reminder Text-Messaging
NCT06587984 ·Status: COMPLETED ·Phase: NA
-
Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine
NCT03287830 ·Status: COMPLETED ·Phase: NA
-
Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children
NCT01662583 ·Status: COMPLETED ·Phase: NA
-
Adult Influenza Vaccination Text Message Reminders
NCT01942824 ·Status: COMPLETED ·Phase: NA
-
Text Messaging Reminders for Influenza Vaccine in Primary Care
NCT01892631 ·Status: COMPLETED ·Phase: NA
-
Pilot Text Message for Influenza Vaccination
NCT01761734 ·Status: COMPLETED ·Phase: NA
-
Nudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu Shot
NCT05493787 ·Status: COMPLETED ·Phase: NA
-
Influenza Vaccine Randomized Educational Trial: Adult
NCT02907645 ·Status: COMPLETED ·Phase: NA
-
Seasonal Influenza Vaccination Reminders for Children With High-risk Conditions
NCT01431183 ·Status: COMPLETED ·Phase: NA
-
Improving Influenza Vaccination Rates Among Health Care Professionals
NCT00404664 ·Status: COMPLETED ·Phase: NA
-
Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood
NCT03898973 ·Status: WITHDRAWN ·Phase: PHASE4
-
Improving Influenza Vaccination Rates in Nurses Through Text Message Reminders : a RCT
NCT02589574 ·Status: UNKNOWN ·Phase: NA
-
Collaborative Efforts to Increase Flu Vaccination
NCT01403649 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults
NCT02233816 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.
NCT02914275 ·Status: COMPLETED ·Phase: PHASE3
-
TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations
NCT01146912 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines
NCT00644059 ·Status: COMPLETED ·Phase: PHASE3